Japanese clinical practice guidelines for oral cancer, 2023

H. Kurita; N. Uzawa; H. Nakayama; T. Abe; S. Ibaraki; Y. Ohyama; K. Uchida; H. Sato; S. Miyabe; T. Abé; N. Kakimoto; A. Kaida; T. Sugiura; M. Kioi; A. Danjo; N. Kitamura; O. Hasegawa; T. Tanaka; N. Ueda; T. Hasegawa; S. Asoda; H. Katsuta; S. Yanamoto; S. Yamada; D. Takeda; T. Suzuki; Y. Ohta; T. Kirita

doi:10.1016/j.ijom.2024.11.012

Japanese clinical practice guidelines for oral cancer, 2023

H. Kurita
, N. Uzawa
, H. Nakayama
, T. Abe
, S. Ibaraki
, Y. Ohyama
, K. Uchida
, H. Sato
, S. Miyabe
, T. Abé
, N. Kakimoto
, A. Kaida
, T. Sugiura
, M. Kioi
, A. Danjo
, N. Kitamura
, O. Hasegawa
, T. Tanaka
, N. Ueda
, T. Hasegawa

S. Asoda, H. Katsuta, S. Yanamoto, S. Yamada, D. Takeda, T. Suzuki, Y. Ohta, T. Kirita

歯科・口腔外科学

研究成果: Review article › 査読

6 被引用数 (Scopus)

抄録

The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.

本文言語	English
ページ（範囲）	461-476
ページ数	16
ジャーナル	International Journal of Oral and Maxillofacial Surgery
巻	54
号	5
DOI	https://doi.org/10.1016/j.ijom.2024.11.012
出版ステータス	Published - 2025 5月

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

外科
口腔外科
耳鼻咽喉科学

文献へのアクセス

10.1016/j.ijom.2024.11.012

他のファイルとリンク

引用スタイル

Kurita, H., Uzawa, N., Nakayama, H., Abe, T., Ibaraki, S., Ohyama, Y., Uchida, K., Sato, H., Miyabe, S., Abé, T., Kakimoto, N., Kaida, A., Sugiura, T., Kioi, M., Danjo, A., Kitamura, N., Hasegawa, O., Tanaka, T., Ueda, N., ... Kirita, T. (2025). Japanese clinical practice guidelines for oral cancer, 2023. International Journal of Oral and Maxillofacial Surgery, 54(5), 461-476. https://doi.org/10.1016/j.ijom.2024.11.012

Kurita, H, Uzawa, N, Nakayama, H, Abe, T, Ibaraki, S, Ohyama, Y, Uchida, K, Sato, H, Miyabe, S, Abé, T, Kakimoto, N, Kaida, A, Sugiura, T, Kioi, M, Danjo, A, Kitamura, N, Hasegawa, O, Tanaka, T, Ueda, N, Hasegawa, T, Asoda, S, Katsuta, H, Yanamoto, S, Yamada, S, Takeda, D, Suzuki, T, Ohta, Y & Kirita, T 2025, 'Japanese clinical practice guidelines for oral cancer, 2023', International Journal of Oral and Maxillofacial Surgery, vol. 54, no. 5, pp. 461-476. https://doi.org/10.1016/j.ijom.2024.11.012

@article{72857c9050df44f6ad91d66f55b996e3,

title = "Japanese clinical practice guidelines for oral cancer, 2023",

abstract = "The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.",

keywords = "Diagnosis, Mouth neoplasms, Patient care, Practice guideline, Therapeutics",

author = "H. Kurita and N. Uzawa and H. Nakayama and T. Abe and S. Ibaraki and Y. Ohyama and K. Uchida and H. Sato and S. Miyabe and T. Ab{\'e} and N. Kakimoto and A. Kaida and T. Sugiura and M. Kioi and A. Danjo and N. Kitamura and O. Hasegawa and T. Tanaka and N. Ueda and T. Hasegawa and S. Asoda and H. Katsuta and S. Yanamoto and S. Yamada and D. Takeda and T. Suzuki and Y. Ohta and T. Kirita",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2025",

month = may,

doi = "10.1016/j.ijom.2024.11.012",

language = "English",

volume = "54",

pages = "461--476",

journal = "International Journal of Oral and Maxillofacial Surgery",

issn = "0901-5027",

publisher = "Churchill Livingstone",

number = "5",

}

TY - JOUR

T1 - Japanese clinical practice guidelines for oral cancer, 2023

AU - Kurita, H.

AU - Uzawa, N.

AU - Nakayama, H.

AU - Abe, T.

AU - Ibaraki, S.

AU - Ohyama, Y.

AU - Uchida, K.

AU - Sato, H.

AU - Miyabe, S.

AU - Abé, T.

AU - Kakimoto, N.

AU - Kaida, A.

AU - Sugiura, T.

AU - Kioi, M.

AU - Danjo, A.

AU - Kitamura, N.

AU - Hasegawa, O.

AU - Tanaka, T.

AU - Ueda, N.

AU - Hasegawa, T.

AU - Asoda, S.

AU - Katsuta, H.

AU - Yanamoto, S.

AU - Yamada, S.

AU - Takeda, D.

AU - Suzuki, T.

AU - Ohta, Y.

AU - Kirita, T.

PY - 2025/5

Y1 - 2025/5

N2 - The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.

AB - The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.

KW - Diagnosis

KW - Mouth neoplasms

KW - Patient care

KW - Practice guideline

KW - Therapeutics

UR - https://www.scopus.com/pages/publications/85213017898

UR - https://www.scopus.com/pages/publications/85213017898#tab=citedBy

U2 - 10.1016/j.ijom.2024.11.012

DO - 10.1016/j.ijom.2024.11.012

M3 - Review article

C2 - 39721909

AN - SCOPUS:85213017898

SN - 0901-5027

VL - 54

SP - 461

EP - 476

JO - International Journal of Oral and Maxillofacial Surgery

JF - International Journal of Oral and Maxillofacial Surgery

IS - 5

ER -

Japanese clinical practice guidelines for oral cancer, 2023

抄録

UN SDG

ASJC Scopus subject areas

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル